Novel Treatment Paradigms: Primary IgA Nephropathy

IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. Approximately 30% to 45% of patients progress to kidney failure (KF) within 20 to 25 years of diagnosis, and there has long been a lack of effective treatments. The therapeutic landscape in IgAN is rapidly evolving, driv...

Full description

Saved in:
Bibliographic Details
Main Authors: Haresh Selvaskandan, Jonathan Barratt, Chee Kay Cheung
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:Kidney International Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024923016157
Tags: Add Tag
No Tags, Be the first to tag this record!